Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Baylor College of Medicine AstraZeneca |
---|---|
Information provided by: | Baylor College of Medicine |
ClinicalTrials.gov Identifier: | NCT00388739 |
Hypothesis: Initiating chronic management treatment plans in conjunction with an asthma educational intervention in the pediatric Emergency Department (ED) with anti-inflammatory medication will result in an improvement of ED revisits (and unscheduled return visits). Chronic management intitiation in conjunction with an asthma educational intervention in the pediatric ED with anti-inflammatory medication will also result in improved Quality of Life measure.
Specific aims: 1. To demonstrate that the initiation controller medication therapy in conjunction with asthma education will result in:
Improved Quality of Life as measured by Bukstein’s ITG Quality of Life measure.
2. To describe the relationship of the initiation of controller medication therapy in conjunction with asthma education with well child visits, missed school/daycare days and behavioral capabilities.
Objective: To determine the impact of beginning chronic asthma medication regimens after an educational intervention in the ED in pediatric patients 1-18 years of age with mild to moderate persistent asthma.
Long-term goal/purpose: To demonstrate the success of a model of care that utilizes the emergency department physician to initiate National Asthma Education and Prevention Program (NAEPP) guided chronic asthma therapy in children 1-18 years of age. This model will attempt to bridge the gap in initiation of chronic asthma therapy currently left by a failure of both emergency department and primary care physicians.
Condition | Intervention |
---|---|
Asthma |
Drug: Pulmicort Behavioral: TEDAS ED Educational Intervention |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department |
Estimated Enrollment: | 251 |
Study Start Date: | November 2006 |
Ages Eligible for Study: | 1 Year to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Troy Bush, B.S. | 832-824-5459 | tbush@bcm.edu |
United States, Texas | |
Texas Children's Hospital | |
Houston, Texas, United States, 77030 |
Principal Investigator: | Charles B Macias, MD, MPH | Baylor College of Medicine |
Study ID Numbers: | IRUSBUPR0045 |
Study First Received: | October 13, 2006 |
Last Updated: | October 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00388739 |
Health Authority: | United States: Institutional Review Board |
Pediatric Asthma Pulmicort TEDAS ED Acute exacerbation of asthma Chronic asthma |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases Budesonide |
Hypersensitivity, Immediate Emergencies Asthma Respiratory Hypersensitivity |
Anti-Inflammatory Agents Respiratory System Agents Disease Attributes Bronchial Diseases Immune System Diseases Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Anti-Asthmatic Agents |
Hormones Glucocorticoids Pharmacologic Actions Pathologic Processes Autonomic Agents Therapeutic Uses Peripheral Nervous System Agents Bronchodilator Agents |